title: Anticancer drugs: Selectively targeting proteins for degradation.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D015195:Drug Design; D009687:Nuclear Proteins / Q000378:metabolism*; D010447:Peptide Hydrolases / Q000378:metabolism*; D010797:Phthalimides / Q000737:chemistry*; D059748:Proteolysis / Q000187:drug effects*; D013792:Thalidomide / Q000031:analogs & derivatives*; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D001381:Azepines; D009687:Nuclear Proteins; D010797:Phthalimides; D014157:Transcription Factors; D013792:Thalidomide; D010447:Peptide Hydrolases